HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD.
Hubei Longxiang Pharmaceutical Technology Co., Ltd. - Home Page
Hubei Longxiang Pharmaceutical Technology Co., Ltd. was founded in January 2008 with a registered capital of 122 million yuan. The controlling shareholder is Tianjin Ruipu Biotechnology Co., Ltd. (stock code: 300119). Longxiang Pharmaceutical was listed on the New Third Board in April 2017, stock code: 871082. It has more than 340 employees and total assets of 560 million yuan.
- Type
- Manufacturer
- Location
- Wuxue, China
- Website
- https://www.lxpharm.com
- Categories
- Pharmaceutical Manufacturing, Chemicals & Plastics, Veterinary Products & Animal Health
Listed in a source registry
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- domain-registered (green), checked 2026-08-09 Domain registry record
- debarment-clear (green), checked 2026-08-09 OpenSanctions
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- sanctions-clear (green), checked 2026-08-09 OpenSanctions
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)
- Chemical substances imported into the EU above 1 tonne/year must be REACH-registered. ECHA (REACH)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)